Downloads provided by UsageCounts
Corona Immunitas was a Switzerland-wide, population-base SARS-CoV-2 study, assessing the seroprevalence and other study outcomes over six phases, starting in 2020 and ending in 2023. This entry describes the central database of study phases 5 and 6. Study phases 1 to 4 have been described elsewhere. This entry consists of the documentation of the database, the guide how to get access to the data and the description of available variables.
Supporters (ordered alphabetically): Cantons of Basel-Landschaft, Basel-Stadt and Vaud CSS Versicherung Economiesuisse Ernst Göhner Stiftung Frontiers Helsana Versicherung Swiss Federal Office of Public Health Swiss School of Public Health (SSPH+) Symphasis Takeda ViiV Healthcare Zürcher Handelskammer Zürich Versicherung
E-cohort, SARS-CoV-2, Epidemiology, Serosurvey, Population-based, Switzerland
E-cohort, SARS-CoV-2, Epidemiology, Serosurvey, Population-based, Switzerland
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 59 | |
| downloads | 70 |

Views provided by UsageCounts
Downloads provided by UsageCounts